AI 检索
AI 阅读
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Early Nivolumab addition to Regorafenib in patients with hepatocellular carcinoma progressing under 1st line therapy (GOING trial). Interim analysis and safety profile

Marco Sanduzzi Zamparelli,Ana M. Matilla,Jose Luis Lledo,Sergio Munoz Martinez,Maria Varela,Mercedes Inarrairaegui,Christie Perello,Beatriz Minguez,Neus Llarch,Laura Marquez Perez,Antonio Guerrero,Gemma Iserte,Andres Castano-Garcia,Laura Carrion,Jordi Rimola,Maria Angeles Garcia-Criado,Gema Domenech,Loreto Boix,Jordi Bruix,Maria Reig

JOURNAL OF CLINICAL ONCOLOGY（2022）

引用 4|浏览19
暂无评分
关键词
hepatocellular carcinoma,regorafenib,early nivolumab addition
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要